Evidence map›Paper›PMID 40050276›Full record

ArticleNature communications2025

Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William Gradishar and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

R C CoombesImperial College, South Kensington, London, UK.ORCID http://orcid.org/0000-0002-4811-1100
Sacha HowellDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Simon R LordEarly Phase Clinical Trials Unit, Department of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-7946-5609
Laura KennyImperial College, South Kensington, London, UK.
Janine MansiGuy's and St Thomas' NHS Foundation Trust, London, UK.
Zahi MitriOHSU Knight Cancer Institute, Portland, OR, USA.ORCID http://orcid.org/0000-0001-8765-7723
Carlo PalmieriUniversity of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0001-9496-2718
Linnea I ChapUniversity of California, Los Angeles, CA, USA.
Paul RichardsBlue Ridge Cancer Center, Salem, VA, USA.
William GradisharNorthwestern University, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-2772-3140
Sagar SardesaiUS Oncology Research, OHC, Cincinnati, OH, USA.
Jason MelearBaylor University Medical Center, Texas Oncology, Dallas, TX, USA.
Joyce O'ShaughnessyBaylor University Medical Center, Texas Oncology, Dallas, TX, USA.
Patrick WardUS Oncology Research, OHC, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-7800-4840
Pavani ChalasaniUniversity of Arizona Cancer Center, Tucson, AZ, USA.
Tobias ArkenauSarah Cannon Research Institute, London, UK.
Richard D BairdCancer Research UK Cambridge Centre, Cambridge, UK.
Rinath JeselsohnDana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-7996-7529
Simak AliImperial College, South Kensington, London, UK.ORCID http://orcid.org/0000-0002-1320-0816
Glen ClackCarrick Therapeutics, Dublin, Ireland.
Ashwani BahlCarrick Therapeutics, Dublin, Ireland.
Stuart McIntoshCarrick Therapeutics, Dublin, Ireland.
Matthew G KrebsDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. matthew.krebs@manchester.ac.uk.ORCID http://orcid.org/0000-0001-7540-3064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40050276
PMCPMC11885804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.